Literature DB >> 25264996

Potential Limitations of E-mail and Text Messaging in Improving Adherence in Glaucoma and Ocular Hypertension.

Osamah J Saeedi1, Christine Luzuriaga, Nancy Ellish, Alan Robin.   

Abstract

PURPOSE: To determine how receptive patients are to the use of e-mail and text message reminders for appointments and medications.
METHODS: We conducted a consecutive cross-sectional survey of eligible patients with glaucoma or ocular hypertension at a private glaucoma subspecialty practice with 3 locations from February 2011 to January 2012. Main outcome measures were answers to survey questions regarding how receptive patients are to e-mail and text messaging reminders for appointments and medications.
RESULTS: Of 989 patients, 404 (40.8%) patients reported that e-mail reminders would help remember appointments and 185 (18.7%) reported that they would help for medications. Among those with access to text messaging, 280 (68.9%) reported text messaging would help them remember appointments and 193 (47.5%) reported it would help with medications. Patients who reported e-mail would help them remember medications were more likely to live in an urban location [P=0.05, odds ratio (OR)=1.84], check the internet at least daily (P≤0.001, OR=1.04), check e-mail when not at home or the office (P=0.02, OR=1.62), and know how to open attachments (P=0.03, OR=1.87). Patients who reported that text messaging would help them remember their medications were more likely to be 40 or less (P≤0.001, OR=8.54) and African American (P<0.001, OR=2.59).
CONCLUSIONS: E-mail and text messaging reminders currently may have a limited utility in improving adherence in the general glaucoma population but may be useful in younger patients with glaucoma.

Entities:  

Mesh:

Year:  2015        PMID: 25264996     DOI: 10.1097/IJG.0000000000000150

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  A novel EyePhone© App for improving adherence to glaucoma therapy.

Authors:  Ari Leshno; Dan Gaton; Reut Singer; Elior Eliasi; Ofri Vorobichik-Berar; Shiran Madgar; Ori Stern; Wasim Jaber; Noa Kapelushnik; Alon Skaat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-02       Impact factor: 3.117

2.  Electronic messaging and communication with living kidney donors.

Authors:  Jessica M Ruck; Sheng Zhou; Alvin G Thomas; Shannon L Cramm; Allan B Massie; John R Montgomery; Jonathan C Berger; Macey L Henderson; Dorry L Segev
Journal:  Clin Transplant       Date:  2018-02-05       Impact factor: 2.863

3.  Access to and Experiences with, e-Health Technology Among Glaucoma Patients and Their Relationship with Medication Adherence.

Authors:  Paula Anne Newman-Casey; Olivia J Killeen; Morgan Renner; Alan L Robin; Paul Lee; Michele Heisler
Journal:  Telemed J E Health       Date:  2018-04-23       Impact factor: 3.536

4.  Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015.

Authors:  Paula Anne Newman-Casey; Megan Dayno; Alan L Robin
Journal:  Expert Rev Ophthalmol       Date:  2016-01-22

5.  User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.

Authors:  Olivia J Killeen; Chamisa MacKenzie; Michele Heisler; Ken Resnicow; Paul P Lee; Paula Anne Newman-Casey
Journal:  J Glaucoma       Date:  2016-10       Impact factor: 2.503

Review 6.  Medical Management of Glaucoma in the 21st Century from a Canadian Perspective.

Authors:  Paul Harasymowycz; Catherine Birt; Patrick Gooi; Lisa Heckler; Cindy Hutnik; Delan Jinapriya; Lesya Shuba; David Yan; Radmila Day
Journal:  J Ophthalmol       Date:  2016-11-08       Impact factor: 1.909

7.  Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design.

Authors:  Paula Anne Newman-Casey; Leslie M Niziol; Chamisa K Mackenzie; Kenneth Resnicow; Paul P Lee; David C Musch; Michele Heisler
Journal:  Pilot Feasibility Stud       Date:  2018-07-23

8.  Patient Adherence to Glaucoma Treatment During the COVID-19 Pandemic.

Authors:  Ioanna Mylona; Maria Dermenoudi; Nikolaos M Glynatsis; Mikes N Glynatsis
Journal:  Cureus       Date:  2021-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.